Aiala Lorente-trigos PhD

Aiala Lorente-Trigos is CMC Manager at Novimmune, a biopharmaceutical company based in Geneva (Switzerland) and dedicated to the discovery and development of therapeutic monoclonal antibodies against immune related diseases and cancer. She joined the company in 2012, after 8 years of experience as research scientist in the cancer research field. As CMC Manager in the Bioprocess R&D department, she has been responsible for the coordination of the internal CMC activities of different projects in the pipeline as well as the management of the outsourced activities. These include cell line, process and assay development, drug substance and drug product manufacture, quality control, stability studies and IMP release to support preclinical and clinical studies.